164 related articles for article (PubMed ID: 7841038)
21. Detection of human herpesvirus-8 DNA in bone marrow biopsies from patients with multiple myeloma and Waldenström's macroglobulinemia.
Agbalika F; Mariette X; Marolleau JP; Fermand JP; Brouet JC
Blood; 1998 Jun; 91(11):4393-4. PubMed ID: 9596693
[No Abstract] [Full Text] [Related]
22. Detection and quantitation of malignant cells in the peripheral blood of multiple myeloma patients.
Billadeau D; Quam L; Thomas W; Kay N; Greipp P; Kyle R; Oken MM; Van Ness B
Blood; 1992 Oct; 80(7):1818-24. PubMed ID: 1391945
[TBL] [Abstract][Full Text] [Related]
23. Discordance between K-ras mutations in bone marrow micrometastases and the primary tumor in colorectal cancer.
Tórtola S; Steinert R; Hantschick M; Peinado MA; Gastinger I; Stosiek P; Lippert H; Schlegel W; Reymond MA
J Clin Oncol; 2001 Jun; 19(11):2837-43. PubMed ID: 11387355
[TBL] [Abstract][Full Text] [Related]
24. Circulating tumour DNA sequence analysis as an alternative to multiple myeloma bone marrow aspirates.
Kis O; Kaedbey R; Chow S; Danesh A; Dowar M; Li T; Li Z; Liu J; Mansour M; Masih-Khan E; Zhang T; Bratman SV; Oza AM; Kamel-Reid S; Trudel S; Pugh TJ
Nat Commun; 2017 May; 8():15086. PubMed ID: 28492226
[TBL] [Abstract][Full Text] [Related]
25. Denaturing gradient gel electrophoresis (DGGE) assay for K-ras and N-ras genes: detection of K-ras point mutations in human lung tumour DNA.
Ridanpää M; Husgafvel-Pursiainen K
Hum Mol Genet; 1993 Jun; 2(6):639-44. PubMed ID: 8353484
[TBL] [Abstract][Full Text] [Related]
26. Waldenström's macroglobulinemia: a clinicopathologic study of 22 cases.
Andriko JA; Aguilera NS; Chu WS; Nandedkar MA; Cotelingam JD
Cancer; 1997 Nov; 80(10):1926-35. PubMed ID: 9366295
[TBL] [Abstract][Full Text] [Related]
27. Polymerase chain reaction/sequencing analysis of ras mutations in paraffin-embedded tissues as compared with 3T3 transfection and polymerase chain reaction/sequencing of frozen tumor deoxyribonucleic acids.
Goodrow TL; Prahalada SR; Storer RD; Manam SV; Leander KR; Kraynak AR; van Zwieten MJ; Nichols WW; Bradley MO
Lab Invest; 1992 Apr; 66(4):504-11. PubMed ID: 1583889
[TBL] [Abstract][Full Text] [Related]
28. RAS gene mutations in multiple myeloma and related monoclonal gammopathies.
Matozaki S; Nakagawa T; Nakao Y; Fujita T
Kobe J Med Sci; 1991 Feb; 37(1):35-45. PubMed ID: 1921261
[TBL] [Abstract][Full Text] [Related]
29. Activation of K-ras by codon 13 mutations in C57BL/6 X C3H F1 mouse tumors induced by exposure to 1,3-butadiene.
Goodrow T; Reynolds S; Maronpot R; Anderson M
Cancer Res; 1990 Aug; 50(15):4818-23. PubMed ID: 2196119
[TBL] [Abstract][Full Text] [Related]
30. IL-1beta expression in IgM monoclonal gammopathy and its relationship to multiple myeloma.
Donovan KA; Lacy MQ; Gertz MA; Lust JA
Leukemia; 2002 Mar; 16(3):382-5. PubMed ID: 11896542
[TBL] [Abstract][Full Text] [Related]
31. K-ras codon 12 and 13 mutations are correlated with differential patterns of tumor cell dissemination in colorectal cancer patients.
Conzelmann M; Linnemann U; Berger MR
Int J Oncol; 2004 Jun; 24(6):1537-44. PubMed ID: 15138598
[TBL] [Abstract][Full Text] [Related]
32. Post-transplantation tumour load in bone marrow, as assessed by quantitative ASO-PCR, is a prognostic parameter in multiple myeloma.
Bakkus MH; Bouko Y; Samson D; Apperley JF; Thielemans K; Van Camp B; Benner A; Goldschmidt H; Moos M; Cremer FW
Br J Haematol; 2004 Sep; 126(5):665-74. PubMed ID: 15327517
[TBL] [Abstract][Full Text] [Related]
33. Bone marrow culture in aplastic anemia.
Barrett AJ; Faille A; Balitrand N; Ketels F; Najean Y
J Clin Pathol; 1979 Jul; 32(7):660-5. PubMed ID: 500837
[TBL] [Abstract][Full Text] [Related]
34. Retrospective analysis of ras gene activation in myeloid leukemic cells.
Lübbert M; Jonas D; Miller CW; Herrmann F; Mertelsmann R; McCormick F; Koeffler HP
Oncogene; 1990 Apr; 5(4):583-7. PubMed ID: 2183160
[TBL] [Abstract][Full Text] [Related]
35. Bone-marrow patterns and survival in Waldenström's macroglobulinaemia.
Chelazzi G; Bettini R; Pinotti G
Lancet; 1979 Nov; 2(8149):965-6. PubMed ID: 91063
[No Abstract] [Full Text] [Related]
36. Mutations of ras genes distinguish a subset of non-small-cell lung cancer cell lines from small-cell lung cancer cell lines.
Mitsudomi T; Viallet J; Mulshine JL; Linnoila RI; Minna JD; Gazdar AF
Oncogene; 1991 Aug; 6(8):1353-62. PubMed ID: 1679529
[TBL] [Abstract][Full Text] [Related]
37. N- and K-ras oncogenes in plasma cell dyscrasias.
Corradini P; Ladetto M; Inghirami G; Boccadoro M; Pileri A
Leuk Lymphoma; 1994 Sep; 15(1-2):17-20. PubMed ID: 7858496
[TBL] [Abstract][Full Text] [Related]
38. IgM myeloma: a report of four cases.
Dierlamm T; Laack E; Dierlamm J; Fiedler W; Hossfeld DK
Ann Hematol; 2002 Mar; 81(3):136-9. PubMed ID: 11904738
[TBL] [Abstract][Full Text] [Related]
39. High frequency mutation in codons 12 and 61 of H-ras oncogene in chewing tobacco-related human oral carcinoma in India.
Saranath D; Chang SE; Bhoite LT; Panchal RG; Kerr IB; Mehta AR; Johnson NW; Deo MG
Br J Cancer; 1991 Apr; 63(4):573-8. PubMed ID: 2021541
[TBL] [Abstract][Full Text] [Related]
40. Direct sequencing of amplified genomic fragments documents N-ras point mutations in myeloid leukemia.
Collins SJ
Oncogene Res; 1988 Sep; 3(2):117-23. PubMed ID: 3067186
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
